USD 0.2
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -3.48 Million CAD | -67.93% |
2022 | -2.07 Million CAD | -303.6% |
2021 | -514.67 Thousand CAD | -418.04% |
2020 | -99.35 Thousand CAD | -178.06% |
2019 | -35.73 Thousand CAD | 52.96% |
2018 | -75.96 Thousand CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -583.74 Thousand CAD | 14.06% |
2023 Q3 | -706.15 Thousand CAD | 51.71% |
2023 FY | - CAD | -67.93% |
2023 Q4 | -679.26 Thousand CAD | 3.81% |
2023 Q2 | -1.46 Million CAD | -128.8% |
2023 Q1 | -639.17 Thousand CAD | -12.4% |
2022 FY | - CAD | -303.6% |
2022 Q2 | -615.82 Thousand CAD | -26.1% |
2022 Q4 | -568.64 Thousand CAD | -19.63% |
2022 Q1 | -488.36 Thousand CAD | -5.46% |
2022 Q3 | -475.35 Thousand CAD | 22.81% |
2021 Q1 | -42.35 Thousand CAD | -238.26% |
2021 Q4 | -463.06 Thousand CAD | 0.0% |
2021 Q2 | -9650.00 CAD | 77.21% |
2021 FY | - CAD | -418.04% |
2020 Q1 | -3563.00 CAD | 0.0% |
2020 Q3 | -84.13 Thousand CAD | 12.17% |
2020 Q2 | -95.79 Thousand CAD | -2588.61% |
2020 Q4 | -12.52 Thousand CAD | 85.12% |
2020 FY | - CAD | -178.06% |
2019 FY | - CAD | 52.96% |
2018 FY | - CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
American Medical Technologies Inc. | -963.95 Thousand USD | -261.88% |
Ansell Limited | 209.86 Million USD | 101.662% |
Ansell Limited | 206.3 Million USD | 101.691% |
BG Medicine, Inc. | - USD | Infinity% |
Biotage AB (publ) | 42.83 Million USD | 108.143% |
BioLife Sciences Inc. | - USD | Infinity% |
CB Scientific, Inc. | -1.62 Million USD | -114.675% |
Psykey, Inc. | -1.29 Million USD | -169.308% |
ConvaTec Group Plc | 455.5 Million USD | 100.766% |
ConvaTec Group Plc | 455.5 Million USD | 100.766% |
Encision Inc. | -544.19 Thousand USD | -541.013% |
Golden Valley Development, Inc | -141.81 Thousand USD | -2359.883% |
Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -3073.256% |
Innovative MedTech Inc. | -7.67 Million USD | 54.542% |
LifePoint, Inc. | -14.2 Million USD | 75.438% |
Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 43.618% |
Paradigm Medical Industries, Inc. | -325 Thousand USD | -973.342% |
QuantRx Biomedical Corporation | - USD | Infinity% |
Remedent, Inc. | -215.23 Thousand USD | -1520.729% |
Reflect Scientific, Inc. | -405.78 Thousand USD | -759.659% |
SmileDirectClub, Inc. | -186.13 Million USD | 98.126% |
Sector 10, Inc. | - USD | Infinity% |
Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.779% |
SheerVision, Inc. | -110.53 Thousand USD | -3056.001% |
United Health Products, Inc. | -2.5 Million USD | -39.411% |
Vasamed, Inc. | -4.57 Million USD | 23.742% |
Wearable Health Solutions, Inc. | -2.26 Million USD | -54.302% |
Yubo International Biotech Limited | -1.17 Million USD | -196.205% |